Nestin:a Novel Marker in Additional Diagnosing Gastrointestinal Stromal Tumors

ZHOU Yang,TAN Yun-shan,HOU Ying-yong,ZHOU Yan-nan,SUJIE Akesu,GAO Feng
DOI: https://doi.org/10.3969/j.issn.1001-7399.2006.05.010
2006-01-01
Experimental Pathology
Abstract:Purpose To study the nestin in the diagnosis of gastrointestinal stromal tumors. Methods There were 165 cases of mesenchymal tumors were investigated the expression of nestin by immunohistochemistry, including 96 CD117-positive GISTs,5 CD117-negtive GISTs,10 oesophagus leiomyomas,33 digestive tract Schwannomas,6 fibromatosis and 15 leiomyosarcomas in abdominal cavity. Results Among 96 cases of CD117-positive GISTs, 94 positive for nestin(in amount of this 70 diffusive positive, 21 moderate positive, 3 local positive), the other two were negative. 4 of the 5 CD117-negative GISTs and 26 of 33 Schwannomas expressed nestin too, only 3 of 15 leiomyosarcomas showed focal positive for nestin. All oesophagus leiomyomas and fibromatosis of intestinal demonstrated negativity for nestin. Conclusions Nestin is a novel marker for GISTs following CD117,It could be efficient in the differerntial diagnosis between GISTs and leiomyomas or fibromatosis. However, other antibody such as S-100 should be used in the differential diagnosis between GISTs and Schwannomas.
What problem does this paper attempt to address?